2024 annual financial data

ImmuCell 2024 Financial results

Direct answer

Revenue was 26,493,169 USD.

Operating income was -1,640,159 USD and net income was -2,156,629 USD.
Operating cash flow was 357,903 USD.

Get free ImmuCell email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
26,493,169 USD
Operating income
-1,640,159 USD
Net income
-2,156,629 USD
Operating cash flow
357,903 USD